More
    Guided Solutions - Connecting Talent With Innovation/div>

    Onward raises $54m to continue neuromodulation trials

    Onward Medical has raised $54m (€50m) via a bookbuild offering, with proceeds going towards ongoing clinical studies and an expected commercial launch of one...

    Sonavex raises $15M to support novel ultrasound solutions

    Sonavex closed a $15 million Series A-2 financing round to support its ultrasound technologies. The Baltimore, Maryland-based Johns Hopkins spinout develops the EchoMark and EchoSure...

    Okami Medical closes $32.5M financing to support catheter tech for peripheral vascular occlusion

    Okami Medical announced it closed a $32.5 million financing round to support its catheter-based technologies. Aliso Viejo, California-based Okami develops multiple technologies for peripheral vascular...

    Diagnostics company Cirdan secured a £7.5m investment

    Lisburn-based medical imaging company Cirdan has raised £7.5 million (€8.9 million) from a pair of investors in a funding round it says will help...

    Horizon Surgical Systems raises $30 million in Series A financing

    Horizon Surgical Systems, Inc., a privately-held, micro-robotics company advancing microsurgery with automated AI-enabled robotics, announced the close of a $30M Series A financing. The...

    Rivermark Medical closes $30 million Series C financing to advance FloStent™ system for benign prostatic hyperplasia

    Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), closed a $30 million Series C financing round. The round was...

    Siloton secures £860k to advance eye imaging chip for AMD

    UK-based eye health start-up Siloton has scored £860,000 in additional funding to drive to market its optical coherence tomography (OCT) chip technology designed to...

    ShiraTronics raises $66M to support implantable migraine therapy

    ShiraTronics closed a $66 million Series B financing round to support its Migraine Therapy System. The Minneapolis-based company designed its minimally invasive implantable neuromodulation...

    MONCYTE Health raises €1M to advance personalised treatment for high cholesterol

    MONCYTE Health has announced the closure of a 1 million EUR seed round to fund its go-to-market strategy. The company's technology is designed to...

    Latest articles